CMS certification 043300
Arkansas Children's Hospital
1 Children's Way, Slot 301, Little Rock, AR 72202
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.
Not reported for this hospital
CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $293,561
- 2020 $373,315
- 2021 $324,211
- 2022 $322,817
- 2023 $240,225
- 2024 $111,471
- 2025 $38,545
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $14,354 | 8 |
| Debt forgiveness | $5,814 | 3 |
| Speaking, teaching and other services | $5,390 | 10 |
| Charitable contributions | $75 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| MED-EL Corporation | $9,090 | 1 |
| Stryker Corporation | $5,814 | 3 |
| Pfizer INC. | $4,800 | 1 |
| Novartis Pharmaceuticals Corporation | $4,414 | 1 |
| KARL STORZ Endoscopy-America | $4,143 | 1 |
| Tandem Diabetes Care, Inc. | $3,800 | 6 |
| Cumberland Pharmaceuticals, Inc. | $3,699 | 2 |
| National Marrow Donor Program | $1,590 | 4 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| THE UNITED STATES PEDIATRIC MULTICENTER PNEUMOCOCCAL SURVEILLANCEWI227301 PFIZER INC. | $4,800 |
| A One Month, Investigator and Participant Blinded Study to Investigate the Efficacy and Safety of Remibrutinib (LOU064) at Multiple Dose Levels in Ad… Novartis Pharmaceuticals Corporation | $4,414 |
| ORAL IFETROBAN IN SUBJECTS WITH DUCHENNE MUSCULAR DYSTROPHY (DMD) Cumberland Pharmaceuticals, Inc. · NCT03340675 | $3,699 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Arkansas Children's Hospital
Does Arkansas Children's Hospital have an emergency room?
Yes. CMS lists emergency services at Arkansas Children's Hospital.
Does Arkansas Children's Hospital receive money from drug and device companies?
Drug and device makers reported $38,545 in payments to Arkansas Children's Hospital for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.